Sunday, 22 July 2018 - 23:28
  • it
  • de
  • en
  • fr

Sanofi Pasteur

Vaccines: Sanofi acquires Protein Science

Sanofi announced it has completed the acquisition of Protein Sciences, a US-based biotech company focusing on vaccines. Thanks to this acquisition, Sanofi Pasteur can now add a promising influenza vaccine to its portfolio: Flublok. It is the only recombinant protein-based…

Sanofi Pasteur, Fiocruz and WRAIR to collaborate against Zika

Sanofi and Sanofi Pasteur announced today they have entered into a collaboration agreement with Oswaldo Cruz Foundation – by means of its institute known as Bio-Manguinhos/Fiocruz – and the Walter Reed Army Institute of Research (WRAIR), to develop a Zika…